NDC product
Diclofenac Sodium
NDC 0228-2550 · Actavis Pharma, Inc.
Key facts
| Product NDC | 0228-2550 |
|---|---|
| Proprietary name | Diclofenac Sodium |
| Nonproprietary name | Diclofenac Sodium |
| Substances | DICLOFENAC SODIUM |
| Dosage form | TABLET, DELAYED RELEASE |
| Route | ORAL |
| Labeler | Actavis Pharma, Inc. |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Application number | ANDA074514 |
| Pharmacologic classes | Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC] |
| Marketing start | Mar 26, 1996 |
| Marketing end | Mar 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory